NVO - Novo Nordisk: Patients on Wegovy maintain weight loss over four years
2024-05-14 04:32:51 ET
More on Novo Nordisk
- FTC Cracks Down On Novo Nordisk's Ozempic
- Novo Nordisk 2024 Q1 - Earnings Call Presentation
- Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
- Novo Nordisk hemophilia candidate Mim8 meets primary goals in phase 3 trial
- BoA raises 2024 Novo Nordisk Wegovy sales estimates on prescription trends